Results 111 to 120 of about 28,261 (176)

Development of an EBOV-GP virus entry system and investigation of the anti-EBOV activity of an extract of Prunella vulgaris and Investigation of the regulatory role of IL-34 in macrophages and CD4+ T lymphocytes during HIV-1 infection [PDF]

, 2016
In this study, we developed an EBOV-glycoprotein (GP) pseudotyped HIV-1-based vector system for the screening of anti-EBOV-GP agent(s). Based on this system, we demonstrated that an aqueous extract (CHPV) from the Chinese herb Prunella vulgaris displayed
Zhang, Xu
core  

Early detection of immunoglobulin A against a vaccine backbone protein enables fast, durable, and objective identification of individuals vaccinated against Ebola virus. [PDF]

EBioMedicine
Posadas O, Berry IM, Callier V, Kennedy SB, Kieh M, Browne SM, Mbaya OT, Hensley K, Hensley LE, Kuhn JH, Crozier I, Davey RT, Lane HC, Follmann DA, Khurana S.   +14 more
europepmc   +1 more source

Species breadth is a preparedness metric: lessons from the 2026 Bundibugyo virus disease outbreak. [PDF]

Emerg Microbes Infect
Hassan AM, Yusuf AA, Hirsi AM, Khalif IA, Maxamed AA, Abdi DA.   +5 more
europepmc   +1 more source

Ebola Virus Persistence in Immune-Privileged Niches: Molecular Mechanisms, Host-Virus Interactions, and Therapeutic Opportunities. [PDF]

Microorganisms
Alanazi A, Albalawi WO, Alshammari ES, Alenezi MA, Shahin HEA, Ibrahim MN.   +5 more
europepmc   +1 more source

Ebola Virus RNA Persists in Reproductive Tissues and Sperm of Male <i>Ifnar1</i>^-/- Mice After Resolution of Viremia. [PDF]

Viruses
Webb AL, Schindell BG, Frost K, Soule G, Booth SA, Safronetz D, Kindrachuk J.   +6 more
europepmc   +1 more source

Early insights into predicted efficacy of Ebola monoclonal antibodies for the 2026 Bundibugyo virus disease outbreak. [PDF]

Nat Commun
Nabukeera KC, Luakanda-Ndelemo G, Semawule S, Ayitewala A, Adroba-Tandele P, Walakira A, Amuri-Aziza A, Jansen D, Galiwango R, Kinganda-Lusamaki E, Tebba A, Ngandu C, Ssemaganda A, Tshiani-Mbaya O, Kanyerezi S, Kyokushaba J, Akil-Bandali P, Makoha C, Oundo HR, Kimbonza S, Balinandi S, Mukadi-Bamuleka D, Nakintu V, Nsio J, Mugerwa I, Kadobera D, Euriene D, Mulangu S, Ayouba A, Eliu M, Gidudu S, Kyobe Bosa H, Wayengera M, Rimoin AW, Lubwama B, Kagirita A, Ahuka-Mundeke S, Mwamba D, Kambugu A, Kaleebu P, Happi C, Liesenborghs L, Carroll MW, Maes P, Nachega JB, Peeters M, Akilimali P, Bahatungire R, Muruta A, Kindrachuk J, Rambaut A, Kyabayinze D, Olaro C, Vercauteren K, Muyembe-Tamfum JJ, Nabadda S, Atwine D, Jjingo D, Wawina-Bokalanga T, Mbala-Kingebeni P, Ssewanyana I.   +60 more
europepmc   +1 more source

Differential glycosylation in the envelope glycoprotein enhances DC-SIGN-mediated cell entry of the West African Ebolavirus Makona. [PDF]

Emerg Microbes Infect
García-Bernalt Diego J, Lasala F, Luczkowiak J, Delaunay C, Noriega MA, Malvar O, Thépaut M, Rivas G, Fieschi F, Canales Á, Casasnovas JM, Delgado R.   +11 more
europepmc   +1 more source

A small molecule inhibits Ebola virus entry through glycoprotein stabilization. [PDF]

Nat Commun
Bu F, Ye G, Sharma KL, La Rosa B, Palaniappan M, Matzuk MM, Young DW, Turner-Hubbard H, Morsheimer K, Owen C, Toth K, Cameron M, Davey R, Chamakuri S, Dosa P, Li F.   +15 more
europepmc   +1 more source

Identification of Host Gene Transcripts by Machine Learning and Their Application to Predict Outcome in Ebola Virus Disease. [PDF]

J Infect Dis
Pérez JG, Rickett NY, Günther S, Kerber R, Ng LFP, Fletcher T, MacGill T, Myers T, Orr R, Carroll MW, Blake N, Hiscox JA.   +11 more
europepmc   +1 more source

Multiplex pan-filovirus assay performance and reproducibility across varied geographical and resource settings. [PDF]

PLoS One
Smith OA, Merritt S, Kompany JP, Hoff NA, Wong TAS, Kamara V, Tambu M, Halbrook M, Kindrachuk J, Barrall AL, Musene K, Martin SA, Berestecky J, Orr R, Myers T, MacGill T, Muyembe-Tamfum JJ, Kaba D, Mbala-Kingebeni P, Rimoin AW, Lehrer AT.   +20 more
europepmc   +1 more source